Glypicans and eye drainage: a new path to lowering eye pressure
Official title: Role of Glypicans in Trabecular Meshwork Function, IOP, and Glaucoma
Funded at Duke University · NIH-11418904 · Data updated 2026-11-12
This grant studies how certain surface molecules called glypicans influence eye fluid drainage and pressure in glaucoma, with the goal of finding safer ways to lower pressure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | September 30, 2024 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $496,633 |
| NIH project number | 5R01EY036373-03 |
| Project ID | NIH-11418904 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with ocular hypertension or glaucoma who are candidates for future drug trials once targets are validated.
✕Less likely to help
Individuals without ocular hypertension or glaucoma or those not eligible for future trials may not benefit.
What this research studies
Glaucoma is a leading cause of blindness linked to high eye pressure from blocked fluid drainage. The project looks at how glypicans affect the trabecular meshwork’s cell framework and cell contacts that control outflow. By studying these molecules in human eye cells, the researchers aim to identify new targets for drugs that reduce pressure with fewer side effects. The work builds on recent findings that glypicans may play a key role in actin contraction and cell adhesion in drainage tissues. If successful, this could guide the development of novel therapies for ocular hypertension and glaucoma.
Why it matters
Potential benefit: Could lead to new, safer treatments that lower eye pressure and reduce glaucoma risk.
How similar studies have gone: Preliminary data suggest glypicans influence TM cell behavior and IOP-related pathways, with potential for translational drug development.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Rao, P Vasantha — Duke University
- Study coordinator: Rao, P Vasantha
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Comparing tube positions in glaucoma implants to protect corneal cells
This trial compares two tube placements for glaucoma drainage implants to see which better protects corneal cells and controls eye pressure in people with uncontrolled glaucoma.
-
Automated topographic test for glaucoma detection and progression
A new automated method uses topographic structure-function mapping to help diagnose glaucoma earlier and track its progression in patients.
-
Using AI on eye scans and genes to predict glaucoma risk
This project uses artificial intelligence on eye scans, vision tests, and genetic information to find people most likely to develop or have worsening glaucoma.
-
AI-based glaucoma screening in community health centers
A new, easy-to-use AI screening approach will be tested in federally funded health centers to help identify people at risk for glaucoma, especially in communities with higher risk.
-
Understanding how glaucoma genes control eye cell function
A long-term research project will study how genetic factors affect eye cells in adults with glaucoma to uncover new ideas for protecting vision.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.